Who are 2137.HK's closest competitors?

The closest Biotechnology peers to Brii (2137.HK) are VRTX, REGN, MRNA. Compare valuation, margins, growth, and insider activity side by side.

How does 2137.HK compare to Biotechnology peers?

Side-by-side comparison of Brii (2137.HK) against industry peers — P/E, ROE, margins, growth rates, and smart-money positioning.

Which Biotechnology stocks have the highest insider activity?

Rank Biotechnology peers by recent insider buying, congressional activity, and hedge-fund accumulation.

2137.HK vs VRTX, REGN, MRNA

Also trades as: BRIBF (OTC) · $vol 0M

HK$0.86 ($0.11)

-0.01 (-0.58%)

Weekly Expected Move ±4.0%

HK$1 HK$1 HK$1 HK$1 HK$1

HKSE · Healthcare · Biotechnology · Tech Score Sell · Power 30 · HK$620.2M mcap · 595M float · 0.117% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

#147 of 155

Biotechnology

Healthcare · Small Cap · 12 peers

Technical Signal Map

6 Bullish

0 Neutral

7 Bearish

Peer Comparison

Symbol	Mkt Cap	P/E	ROE %	ROIC %	Net Mgn %	Rev Grw %	Piotroski	Signal	1Y Ret %
2137.HK Brii Biosciences Limited	$620M	-3.1	-21.4	-110.0	—	-70.3	3	BEARISH	-59.6
002821.SZ Asymchem Laboratories (Tianjin) Co., Ltd.	$63B	65.0	5.9	10.1	12.0	12.6	4	BULLISH	92.7
300347.SZ Hangzhou Tigermed Consulting Co., Ltd	$57B	730.0	0.5	3.2	-24.2	12.2	6	BULLISH	-10.5
688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.	$50B	18.8	36.7	59.1	52.1	40.8	5	BULLISH	18.5
9926.HK Akeso, Inc.	$100B	-87.7	-26.2	-26.7	-23.5	-5.1	2	BULLISH	-35.5
2269.HK WuXi Biologics (Cayman) Inc.	$232B	38.5	20.8	28.7	20.7	29.7	9	BULLISH	77.0
300759.SZ Pharmaron Beijing Co., Ltd.	$87B	46.4	11.2	7.8	10.3	15.9	5	BULLISH	58.4
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	$114B	—	—	—	—	—	—	LEAN BEAR	—
002422.SZ Sichuan Kelun Pharmaceutical Co., Ltd. Class A	$65B	35.2	7.6	6.3	14.7	-4.2	3	LEAN BEAR	12.0
1801.HK Innovent Biologics, Inc.	$171B	116.1	14.2	72.6	14.5	116.5	8	BEARISH	0.3
9995.HK RemeGen Co., Ltd.	$43B	11.3	108.4	139.6	83.4	283.5	7	BEARISH	-5.5
688331.SS RemeGen Co. Ltd. Class A	$65B	11.3	109.1	140.3	83.4	286.2	7	BEARISH	87.4
002653.SZ Haisco Pharmaceutical Group Co., Ltd.	$70B	70.8	22.1	14.4	19.4	35.9	7	BEARISH	4.6
2137.HK Brii Biosciences Limited	$620M	-3.1	-21.4	-110.0	—	-70.3	3	BEARISH	-59.6
002821.SZ Asymchem Laboratories (Tianjin) Co., Ltd.	$63B	65.0	5.9	10.1	12.0	12.6	4	BULLISH	92.7
300347.SZ Hangzhou Tigermed Consulting Co., Ltd	$57B	730.0	0.5	3.2	-24.2	12.2	6	BULLISH	-10.5
688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.	$50B	18.8	36.7	59.1	52.1	40.8	5	BULLISH	18.5
9926.HK Akeso, Inc.	$100B	-87.7	-26.2	-26.7	-23.5	-5.1	2	BULLISH	-35.5
2269.HK WuXi Biologics (Cayman) Inc.	$232B	38.5	20.8	28.7	20.7	29.7	9	BULLISH	77.0
300759.SZ Pharmaron Beijing Co., Ltd.	$87B	46.4	11.2	7.8	10.3	15.9	5	BULLISH	58.4
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	$114B	—	—	—	—	—	—	LEAN BEAR	—
002422.SZ Sichuan Kelun Pharmaceutical Co., Ltd. Class A	$65B	35.2	7.6	6.3	14.7	-4.2	3	LEAN BEAR	12.0
1801.HK Innovent Biologics, Inc.	$171B	116.1	14.2	72.6	14.5	116.5	8	BEARISH	0.3
9995.HK RemeGen Co., Ltd.	$43B	11.3	108.4	139.6	83.4	283.5	7	BEARISH	-5.5
688331.SS RemeGen Co. Ltd. Class A	$65B	11.3	109.1	140.3	83.4	286.2	7	BEARISH	87.4
002653.SZ Haisco Pharmaceutical Group Co., Ltd.	$70B	70.8	22.1	14.4	19.4	35.9	7	BEARISH	4.6

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

2137.HK vs Benchmarks

ROIC

2137.HK

-110.0

Industry

11.2

Revenue Growth

2137.HK

-70.3

Sector

10.1

P/E Ratio

2137.HK

-3.1

Sector

23.7

ROE

2137.HK

-21.4

Sector

-28.8

Piotroski F

2137.HK

3.0

Sector

4.0

2137.HK HKSE

Technical Signal Map

Peer Comparison

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

2137.HK vs Benchmarks

Sign in to InsiderStreet